Geneseeq Technology is developing a blood test that uses cell-free DNA (cfDNA) and artificial intelligence (AI) to detect early-stage pancreatic ductal adenocarcinoma — the…
Pancreatic cancer is a rare form of cancer that begins in the pancreas, an essential organ involved in digestion and blood sugar control, but can spread, or metastasize, to other parts of the body. The disease can cause symptoms such as abdominal pain, nausea, fatigue, and jaundice, or a yellowing of the skin and eyes. However, diagnosing pancreatic cancer is difficult because most of its symptoms are unspecific and don’t become evident until the disease has already advanced significantly.
Treatment for pancreatic cancer, a rare cancer that arises from cells in the pancreas, may involve a variety of different approaches, depending on factors such as the stage of disease and a person’s health status. Due to the aggressive nature of the disease, pancreatic cancer survival rates are relatively low. An early diagnosis, when the cancer can still be treated with potentially curative surgery, is critical to improve a person’s pancreatic cancer prognosis. When surgery is not an option, chemotherapy, radiation, and other supportive care measures may help control the cancer and keep patients comfortable for as long as possible.
PANCREATIC CANCER
Geneseeq Technology is developing a blood test that uses cell-free DNA (cfDNA) and artificial intelligence (AI) to detect early-stage pancreatic ductal adenocarcinoma — the…
PANCREATIC CANCER
Adding the experimental therapy elraglusib to standard chemotherapy led to statistically significant improvements in survival for people with metastatic pancreatic ductal adenocarcinoma (PDAC), a form…
PANCREATIC CANCER
Theriva Biologics’ experimental treatment VCN-01 safely increased survival when used in addition to chemotherapy for people with newly diagnosed metastatic pancreatic ductal adenocarcinoma (PDAC),…
PANCREATIC CANCER
The U.S. Food and Drug Administration (FDA) has given Verastem Oncology the green light to start clinical testing of its oral treatment candidate VS-7375…
PANCREATIC CANCER
Blood levels of the MUC5AC protein could help predict outcomes in people who have surgery for pancreatic ductal adenocarcinoma (PDA), the most common type of…
PANCREATIC CANCER
A combination of drugs to block two proteins, called PRMT5 and Chk1, may be effective for the treatment of pancreatic cancer, according to new…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.